Ex vivo generation of clinical relevant amounts of human natural killer cells from CD34+haematopoietic progenitor cells for immunotherapy against acute myeloid leukaemia

被引：0
|
作者：
Spanholtz, J. [1 ]
Tordoir, M. [1 ]
Groenewegen, D. [2 ]
de Witte, T. [1 ]
Dolstra, H. [1 ]
机构：
[1] UMCN, Nijmegen, Netherlands
[2] Glycostem Therapeut, Nijmegen, Netherlands
来源：
BONE MARROW TRANSPLANTATION | 2008年 / 41卷
关键词：
D O I：
暂无
中图分类号：
Q6 [生物物理学];
学科分类号：
071011 ;
摘要：
引用
收藏
页码：S159 / S159
页数：1
相关论文
共 50 条
  • [1] EX VIVO GENERATION OF CLINICALLY RELEVANT AMOUNTS OF HUMAN NATURAL KILLER CELLS FOR IMMUNOTHERAPY AGAINST ACUTE MYELOID LEUKEMIA
    Spanholtz, J.
    Tordoir, M.
    De Witte, T.
    Dolstra, H.
    HAEMATOLOGICA-THE HEMATOLOGY JOURNAL, 2008, 93 : 240 - 240
  • [2] Ex-Vivo Generation of Clinical Relevant Amounts of NK Cells from CD34+Progenitor Cells for Immunotherapy
    Spanholtz, J.
    Tordoir, M.
    de Witte, T.
    Dolstra, H.
    TISSUE ENGINEERING PART A, 2009, 15 (03) : 697 - 697
  • [3] Preclinical Ex-Vivo Generation of Clinical Relevant Amounts of NK Cells from CD34+Progenitor Cells for Immunotherapy
    Spanholtz, Jan
    de Witte, T. M.
    Tordoir, Marleen
    Dolstra, Harry
    BLOOD, 2008, 112 (11) : 1003 - 1003
  • [4] Ex vivo differentiation of natural killer cells from human umbilical cord blood CD34+ progenitor cells
    Pinho, Maria Joao
    Punzel, Michael
    Sousa, Mario
    Barros, Alberto
    CELL COMMUNICATION AND ADHESION, 2011, 18 (03): : 45 - 55
  • [5] In Vivo Developing Immunotherapy of Ex Vivo Expansion of Human Natural Killer Cells from Thalassemia Patients for Leukaemia
    Alkhaled, M.
    Elazzazy, A. M.
    Almaghrabia, O. A.
    Handgretinger, R.
    INDIAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2022, 84 : 42 - 47
  • [6] Ex-vivo generation of myeloid post-progenitor cells from mobilized peripheral blood CD34(+) cells
    Scheding, S
    Buhring, HJ
    Ziegler, B
    Bock, T
    Kanz, L
    Brugger, W
    BLOOD, 1995, 86 (10) : 912 - 912
  • [7] Clinical scale generation of functional human natural killer cells from umbilical cord blood CD34-positive cells for immunotherapy
    Spanholtz, J.
    Tordoir, M.
    Trilsbeek, C.
    Paardekooper, J.
    de Witte, T.
    Schaap, N.
    Preijers, F.
    Dolstra, H.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S77 - S77
  • [8] In vitro generation of antigen-specific T-cells from CD34+haematopoietic progenitor cells: a new and promising immunotherapeutic strategy
    Snauwaert, S.
    Van Coppernolle, S.
    Verstichel, G.
    Goetgeluk, G.
    Van Caeneghem, Y.
    Vanhee, S.
    Velghe, I.
    Plum, J.
    Kerre, T.
    Vandekerckhove, B.
    BONE MARROW TRANSPLANTATION, 2013, 48 : S30 - S30
  • [9] Clinical Scale Generation of Functional Human Natural Killer Cells From Umbilical Cord Blood CD34-Positive Cells for Immunotherapy
    Spanholtz, Jan
    Tordoir, Marleen
    Trilsbeek, Carel
    Paardekooper, Jos
    Eissens, Diana
    van der Meer, Arnold
    Joosten, Irma
    Preijers, Frank
    de Witte, T. M.
    Schaap, Nicolaas
    Dolstra, Harry
    BLOOD, 2009, 114 (22) : 1045 - 1045
  • [10] LYMPHOKINE REQUIREMENT FOR THE GENERATION OF NATURAL-KILLER-CELLS FROM CD34(+) HEMATOPOIETIC PROGENITOR CELLS
    SHIBUYA, A
    NAGAYOSHI, K
    NAKAMURA, K
    NAKAUCHI, H
    BLOOD, 1995, 85 (12) : 3538 - 3546
12345